Month: April 2026

DUBLIN, IRELAND, April 21, 2026 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 fourth quarter and full year results at 9:00 a.m. ET on May 12, 2026. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing financial results will be issued after the U.S. market closes on May 11, 2026. For those unable to listen to the conference call live, a replay will be available beginning at 12:00 p.m. ET on May 12, 2026, either at www.steris-ir.com or via phone. To access the replay of the call, please use the access code 3141167 and dial 1-855-669-9658 in the United...

PLAINVIEW, N.Y., April 21, 2026 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) plans to release its first quarter 2026 financial results after the market closes on Tuesday, May 5, 2026. The company will host a conference call to review these results starting at 5:00 PM ET that day. To join the call, dial 1-877-407-8029 (toll-free) or 1-201-689-8029. Participants may also access a live webcast of the call by visiting Veeco’s investor relations website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00 PM ET that same evening. About Veeco Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, metal organic chemical vapor deposition (MOCVD), single wafer etch & clean and lithography technologies play...

HUNTINGTON BEACH, Cali., April 21, 2026 (GLOBE NEWSWIRE) — BJ’s Restaurants, Inc. (NASDAQ: BJRI) today announced that it will release its first quarter 2026 results after the market closes on Tuesday, May 5, 2026. The Company will host an investor conference call at 2:00 p.m. (Pacific) that same day. The conference call will be broadcast live over the Internet. To listen to the conference call, please visit the “Investors” page of the Company’s website located at http://www.bjsrestaurants.com several minutes prior to the start of the call to register and download any necessary audio software. An archive of the presentation will be available for 30 days following the call. About BJ’s Restaurants, Inc. BJ’s Restaurants, Inc. is a national casual dining brand with brewhouse roots. Founded in 1978, BJ’s owns and operates over...

TAMPA, Fla., April 21, 2026 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE: HCI) will hold its Annual Meeting of Shareholders on Wednesday, June 10, 2026, at 3:00 p.m. Eastern Time in the 1st Floor Auditorium of HCI’s headquarters at 3802 Coconut Palm Drive, Tampa, Florida. Shareholders of record at the close of business on Monday, April 13, 2026, will be entitled to vote and attend the meeting. Items of business will include the following proposals:To elect one Class B Director and three Class C Directors To ratify the appointment of external auditors To approve, on an advisory basis, the compensation of the named executive officersShareholders will also consider such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof. About HCI Group, Inc. HCI Group, Inc. is a diversified...

– Data from Four Studies Spotlight Rising Clinical Interest & Urgency to Address Cisplatin-Induced Hearing Loss and Its Lasting Impact on Patients – RESEARCH TRIANGLE PARK, N.C., April 21, 2026 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announced that four abstracts evaluating PEDMARK® (sodium thiosulfate injection) were accepted as part of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting program, taking place May 29-June 2, 2026 in Chicago, IL. PEDMARK® is currently approved for pediatric patients one month of age and older with localized, non-metastatic solid tumors, and is also recognized by the National Comprehensive Cancer Network with a 2A recommendation for use in adolescent and young adult patients. Poster Presentation Details: Title:...

NORTHBOROUGH, Mass., April 21, 2026 (GLOBE NEWSWIRE) — Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”) today provided an update on its manufacturing facility in East Providence, Rhode Island. As previously reported, an explosion occurred at Aspen’s manufacturing facility in East Providence, Rhode Island on the evening of April 8, 2026. The explosion damaged a portion of the facility’s production space and required the temporary cessation of operations. The investigation into the cause of the incident is ongoing. Preliminary reports indicate the explosion originated in a specific high-temperature oven. Eleven employees at the facility were transported to local medical facilities for evaluation and were subsequently released. As of April 21, 2026, the facility remains offline. The Company continues to work...

Clinically meaningful efficacy demonstrated in the 8-week follow-up period (weeks 9-16), with a 90% median reduction in clinical seizures over baseline in weeks 9-12 and a 59% median reduction in clinical seizures over baseline in weeks 13-16 New data demonstrate that RAP-219 has a half-life of approximately 22 days RAP-219 was generally well tolerated throughout treatment and follow-up periods BOSTON and SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced results from the follow-up period of its Phase 2a trial of RAP-219 in focal onset seizures (FOS) in a late-breaker podium...

MOUNTLAKE TERRACE, Wash., April 21, 2026 (GLOBE NEWSWIRE) — FS Bancorp, Inc. (NASDAQ: FSBW) (the “Company”), the holding company for 1st Security Bank of Washington (the “Bank”) today reported 2026 first quarter net income of $7.8 million, or $1.02 per diluted share, compared to $8.4 million, or $1.10 per diluted share, for the prior quarter, and $8.0 million, or $1.01 per diluted share, for the comparable quarter one year ago. Pre-tax income of $9.9 million in the first quarter of 2026 increased $440,000, or 4.6%, from $9.5 million in the first quarter of 2025, with the decrease in net income between those periods primarily reflecting a higher effective income tax rate. “We are excited about the announced merger with Pacific West Bancorp that occurred in February and our projected growth into the Portland, Oregon market area later...

ATLANTA, Georgia, April 21, 2026 (GLOBE NEWSWIRE) — Atlantic American Corporation (Nasdaq: AAME) announced today that on April 17, 2026, the Company received a notice from The Nasdaq Stock Market LLC stating that because the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2025 (the “Form 10-K”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission. The Nasdaq notice has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Global Market. The Company has 60 calendar days from the date of the notice to submit to Nasdaq a plan to regain compliance. If Nasdaq accepts the Company’s plan, then Nasdaq may grant the Company up to 180 calendar...